The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of modified FOLIRI plus Panitumumab as first-line treatment in elderly patients with RAS wild-type metastatic colorectal cancer.
 
Athanasios Karampeazis
No Relationships to Disclose
 
Lampros Vamvakas
No Relationships to Disclose
 
Nikolaos K. Kentepozidis
No Relationships to Disclose
 
Athanasios Kotsakis
No Relationships to Disclose
 
Kostas Kalbakis
No Relationships to Disclose
 
Spyros Xynogalos
No Relationships to Disclose
 
Ioannis Sougklakos
Consulting or Advisory Role - Roche
Speakers' Bureau - Sanofi
Research Funding - Amgen
Travel, Accommodations, Expenses - Amgen; Merck Serono
 
Christos E. Emmanouilides
No Relationships to Disclose
 
Alexandra Voutsina
No Relationships to Disclose
 
Dora Hatzidaki
No Relationships to Disclose
 
Vassilis Georgoulias
No Relationships to Disclose